| Financial Year |
March 31 2023 |
| Monetary Funds |
3,725,502,361.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
260,494,124.30 |
| Accounts Receivable |
147,258,390.68 |
| Advances to Suppliers |
215,059,620.91 |
| Other Receivables |
25,793,082.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,082,424,151.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,533,968.13 |
| Total Current Assets |
5,582,065,699.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,388,623,212.04 |
| Investment Properties |
-- |
| Fixed Assetes |
8,481,439,626.11 |
| Under-construction Projects |
846,407,938.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
476,157,497.72 |
| R&D expenses |
-- |
| Goodwill |
1,743,878.83 |
| Long-Term Deferred and Prepaid Expenses |
11,142,503.27 |
| Deferred Income Tax Assets |
55,074,468.72 |
| Other Non-Current Assets |
1,077,870,200.85 |
| Sub-Total of Non-Current Assets |
14,448,644,188.10 |
| Total Assets |
20,030,709,887.37 |
| Short-Term Loans |
2,157,691,993.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
812,617,658.81 |
| Accounts Payable |
1,734,714,328.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,808,331.23 |
| Taxes Payable |
110,224,189.85 |
| Interest Payable |
-- |
| Dividend Payable |
1,660,542.46 |
| Other payables |
229,308,965.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,081,909,526.59 |
| Other Current Liabilities |
72,677,979.37 |
| Sub-Total of Current Liabilities |
7,955,408,688.82 |
| Long-term Loans |
4,623,387,341.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,050,440.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
75,078.65 |
| Deferred Income Tax Liabilities |
41,889,910.11 |
| Other Non-Current Liabilities |
117,776,852.86 |
| Sub-Total of Non-Current Liabilities |
5,009,614,664.89 |
| Total Liabilities |
12,965,023,353.71 |
| Paid-In Capital(Or Share Stock) |
897,866,712.00 |
| Capital Surplus |
2,239,511,812.71 |
| Surplus Reserve |
402,378,678.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,343,173,676.61 |
| Minority Stockholder's Interest |
2,155,344,807.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,910,341,725.97 |
| Owner's Equity（Stockholder's Equity） |
7,065,686,533.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,030,709,887.37 |
